Literature DB >> 14706858

Bone marrow-derived cells contribute to lung regeneration after elastase-induced pulmonary emphysema.

Kota Ishizawa1, Hiroshi Kubo, Mitsuhiro Yamada, Seiichi Kobayashi, Muneo Numasaki, Shinsaku Ueda, Takashi Suzuki, Hidetada Sasaki.   

Abstract

All-trans retinoic acid (ATRA) is known to reverse the anatomic and physiologic signs of pulmonary emphysema. However, the origin of the progenitor cells involved in this lung regeneration remains unclear. Recently, it was shown that bone marrow could be the source of progenitor cells for several cell types. Mice with elastase-induced emphysema were treated with ATRA, granulocyte colony-stimulating factor (G-CSF), or a combination of both. ATRA or G-CSF promoted lung regeneration and increased bone marrow-derived cell (BMC) numbers in alveoli. Combined treatment of both had an additive effect, which indicated that BMC mobilization might be important in lung regeneration.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14706858     DOI: 10.1016/s0014-5793(03)01399-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  87 in total

1.  Maintenance and repair of the lung endothelium does not involve contributions from marrow-derived endothelial precursor cells.

Authors:  Sarah J Ohle; Asha Anandaiah; Attila J Fabian; Alan Fine; Darrell N Kotton
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02-09       Impact factor: 6.914

2.  Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers.

Authors:  Sara K Alford; Edwin J R van Beek; Geoffrey McLennan; Eric A Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-05       Impact factor: 11.205

Review 3.  Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema.

Authors:  Stephen I Rennard; Shinsaku Togo; Olaf Holz
Journal:  Proc Am Thorac Soc       Date:  2006-11

Review 4.  Engraftment of marrow-derived epithelial cells: the role of fusion.

Authors:  Erica L Herzog; Diane S Krause
Journal:  Proc Am Thorac Soc       Date:  2006-11

5.  Pharmacokinetics of a novel agent, R667, in patients with emphysema.

Authors:  Yu-Yuan Chiu; Michael D Roth; Stanley Kolis; David Rogovitz; Brian Davies
Journal:  Br J Clin Pharmacol       Date:  2007-02-23       Impact factor: 4.335

6.  Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation.

Authors:  Jason M Aliotta; Fermin M Sanchez-Guijo; Gerri J Dooner; Kevin W Johnson; Mark S Dooner; Kenneth A Greer; Deborah Greer; Jeffrey Pimentel; Luiz M Kolankiewicz; Napoleon Puente; Sam Faradyan; Paulette Ferland; Elaine L Bearer; Michael A Passero; Mehrdad Adedi; Gerald A Colvin; Peter J Quesenberry
Journal:  Stem Cells       Date:  2007-06-07       Impact factor: 6.277

Review 7.  Stem cells and cell therapies for cystic fibrosis and other lung diseases.

Authors:  Daniel J Weiss
Journal:  Pulm Pharmacol Ther       Date:  2007-12-07       Impact factor: 3.410

8.  Marrow cell infusion attenuates vascular remodeling in a murine model of monocrotaline-induced pulmonary hypertension.

Authors:  Jason M Aliotta; Patrick J Keaney; Rod R Warburton; Michael DelTatto; Mark S Dooner; Michael A Passero; Peter J Quesenberry; James R Klinger
Journal:  Stem Cells Dev       Date:  2009-06       Impact factor: 3.272

Review 9.  Animal models of chronic obstructive pulmonary disease.

Authors:  Joanne L Wright; Manuel Cosio; Andrew Churg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-02       Impact factor: 5.464

Review 10.  The paradoxical dynamism of marrow stem cells: considerations of stem cells, niches, and microvesicles.

Authors:  Peter J Quesenberry; Jason M Aliotta
Journal:  Stem Cell Rev       Date:  2008-07-30       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.